Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
OncoGenex
company
About
OncoGenex develops and commercializes innovative therapies for the treatment of a variety of cancers.
- 51 - 100
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $11.50M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 1991
- Number Of Employee
- 51 - 100
- Operating Status
- Active
OncoGenex’ mission is to meet the challenge of treatment resistance through the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$11.50M
OncoGenex has raised a total of
$11.50M
in funding over 2 rounds. Their latest funding was raised on
Oct 29, 2003 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 29, 2003 | Post-IPO Equity | $11.50M | 1 |
Working Opportunity Fund
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
OncoGenex is funded by 1 investors.
Working Opportunity Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Working Opportunity Fund
|
Yes | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
